Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
Heron Therapeutics is a biotechnology company engaged in drug discovery and development.
Tokyo, JP HQ
Lund, SE HQ
San Diego, US HQ
Valuation ($)839.8 m
Valuation ($)1.6 b
Valuation ($)145 m
Revenue (est.)¥15.6b (FY, 2022)
Revenue (est.)kr956.3m (FY, 2022)
Revenue (est.)$107.7m (FY, 2022)
Cost of goods
Cost of goods¥490m (FY, 2022)
Cost of goodskr90.2m (FY, 2022)
Cost of goods$54.9m (FY, 2022)
Gross profit¥15.7b (FY, 2022)
Gross profitkr866.9m (FY, 2022)
Gross profit$52.8m (FY, 2022)
Net income¥1.8b (FY, 2022)
Net incomekr55.6m (FY, 2022)
Net income($182m) (FY, 2022)